|
Volumn 76, Issue 6, 2011, Pages 574-
|
Comment: Lessons from the clinic: A case of natalizumab-associated PML
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NATALIZUMAB;
MONOCLONAL ANTIBODY;
BRAIN;
CEREBROSPINAL FLUID;
COST;
COST BENEFIT ANALYSIS;
DISEASE COURSE;
DISEASE DURATION;
EVALUATION;
HOSPITAL;
HUMAN;
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT MONITORING;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RISK ASSESSMENT;
SYMPTOM;
TREATMENT OUTCOME;
VIRUS LOAD;
CHEMICALLY INDUCED DISORDER;
UTILIZATION REVIEW;
ANTIBODIES, MONOCLONAL;
HUMANS;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
MAGNETIC RESONANCE IMAGING;
|
EID: 79951659640
PISSN: 00283878
EISSN: 1526632X
Source Type: Journal
DOI: 10.1212/WNL.0b013e31820b35d7 Document Type: Article |
Times cited : (4)
|
References (2)
|